Literature DB >> 16769782

Glucocorticoid resorption and influence on the hypothalamic-pituitary-adrenal axis after intra-articular treatment of the knee in resting and mobile patients.

T Weitoft1, L Rönnblom.   

Abstract

BACKGROUND: Studies have shown that intra-articular glucocorticoid injection treatment for knee synovitis has a better outcome in resting patients than in mobile patients. One reason for this observation might be that rest retards steroid resorption, causing an enhanced local treatment effect.
OBJECTIVES: To study drug resorption and the impact on hormone production in the hypothalamic-pituitary-adrenal axis after intra-articular glucocorticoid administration, with and without postinjection rest.
METHODS: Twenty patients with rheumatoid arthritis and knee synovitis were randomised to either 24 hour bed rest or normal activity after intra-articular glucocorticoid treatment with 20 mg triamcinolone hexacetonide (THA). Serum levels of THA, cortisol, and adrenocorticotropic hormone (ACTH) were followed during 2 weeks.
RESULTS: Short term and reversible decreases in serum cortisol and ACTH levels (p<0.001) were seen, without any significant differences between resting and mobile patients. The THA levels increased similarly in both groups, with the median serum peak seen after 8 hours.
CONCLUSION: Immobilisation does not appear to retard glucocorticoid resorption after intra-articular administration. Further studies are therefore needed to clarify the mechanism behind the beneficial effects of rest after intra-articular glucocorticoid treatment for knee synovitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769782      PMCID: PMC1798213          DOI: 10.1136/ard.2005.041525

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

1.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

2.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

3.  Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate.

Authors:  R D Armstrong; J English; T Gibson; J Chakraborty; V Marks
Journal:  Ann Rheum Dis       Date:  1981-12       Impact factor: 19.103

4.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

5.  Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis.

Authors:  T Weitoft; A Larsson; T Saxne; L Rönnblom
Journal:  Ann Rheum Dis       Date:  2005-04-20       Impact factor: 19.103

6.  A randomized controlled study of post-injection rest following intra-articular steroid therapy for knee synovitis.

Authors:  K Chakravarty; P D Pharoah; D G Scott
Journal:  Br J Rheumatol       Date:  1994-05

7.  Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire.

Authors:  C Ekdahl; K Eberhardt; S I Andersson; B Svensson
Journal:  Scand J Rheumatol       Date:  1988       Impact factor: 3.641

8.  Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration.

Authors:  H Derendorf; H Möllmann; A Grüner; D Haack; G Gyselby
Journal:  Clin Pharmacol Ther       Date:  1986-03       Impact factor: 6.875

9.  Cushing's syndrome with suppression of the hypothalamic-pituitary-adrenal axis after intra-articular steroid injections.

Authors:  M M O'Sullivan; W R Rumfeld; M K Jones; B D Williams
Journal:  Ann Rheum Dis       Date:  1985-08       Impact factor: 19.103

  9 in total
  15 in total

Review 1.  Intra-articular glucocorticoid injections and their effect on hypothalamic-pituitary-adrenal (HPA)-axis function.

Authors:  Philip C Johnston; M Cecilia Lansang; Soumya Chatterjee; Laurence Kennedy
Journal:  Endocrine       Date:  2014-09-03       Impact factor: 3.633

2.  The impact of intra-articular methylprednisolone acetate injection on fructosamine levels in diabetic patients with osteoarthritis of the knee, a case-control study.

Authors:  George Habib; Fahed Sakas; Suheil Artul; Fadi Khazin; Geries Hakim; Adel Jabbour; Haneen Jabaly-Habib
Journal:  Clin Rheumatol       Date:  2016-03-07       Impact factor: 2.980

3.  Intra-articular methylprednisolone acetate injection at the knee joint and the hypothalamic-pituitary-adrenal axis: a randomized controlled study.

Authors:  George Habib; Adel Jabbour; Suheil Artul; Geries Hakim
Journal:  Clin Rheumatol       Date:  2013-08-28       Impact factor: 2.980

Review 4.  Pharmacology of intra-articular triamcinolone.

Authors:  Justin Scherer; K D Rainsford; Colin A Kean; Walter F Kean
Journal:  Inflammopharmacology       Date:  2014-05-14       Impact factor: 4.473

5.  Effects of intra-articular corticosteroid injections on lumbar trabecular density.

Authors:  Jonathon Florance; Robert Hemke; Connie Y Chang; Martin Torriani; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2019-12-13       Impact factor: 2.199

6.  The impact of intra-articular injection of diprospan at the knee joint on blood glucose levels in diabetic patients.

Authors:  George Habib; Fadi Khazin; Fahed Sakas; Geries Hakim; Suheil Artul
Journal:  Eur J Rheumatol       Date:  2018-02-13

Review 7.  Systemic effects of intra-articular corticosteroids.

Authors:  George S Habib
Journal:  Clin Rheumatol       Date:  2009-02-28       Impact factor: 2.980

Review 8.  Progress in intra-articular therapy.

Authors:  Christopher H Evans; Virginia B Kraus; Lori A Setton
Journal:  Nat Rev Rheumatol       Date:  2013-11-05       Impact factor: 20.543

Review 9.  [Safety aspects of the treatment with glucocorticoids for rheumatoid arthritis].

Authors:  Gernot Keyßer
Journal:  Z Rheumatol       Date:  2021-03-11       Impact factor: 1.372

10.  Corticosteroid Injections and COVID-19 Infection Risk.

Authors:  David C Miller; Jaymin Patel; Jatinder Gill; Ryan Mattie; Mathew Saffarian; Byron J Schneider; Adrian Popescu; Vivek Babaria; Zachary L McCormick
Journal:  Pain Med       Date:  2020-08-01       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.